Type 2 Diabetes Mellitus Recruiting Phase 4 Trials for Metformin (DB00331)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus,Type 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

DBCOND0029752 (Type 2 Diabetes Mellitus)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02338921Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination TherapyTreatment
NCT02315287Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes ManagementTreatment
NCT01717911ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate HyperglycemiaTreatment
NCT02438397the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix InsulinTreatment
NCT02501616Effect of Dapagliflozine on Systemic and Renal Endothelial FunctionTreatment
NCT03359837Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyTreatment
NCT03196362Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 DiabetesTreatment
NCT02501850The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)Treatment
NCT03819790The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South AsiansTreatment
NCT02911792Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With HyperfiltrationTreatment
NCT02409238Insulin Resistance and Mild Cognitive Impairment (IRMCI) StudyTreatment